Drugs / Trimipramine

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) SURMONTIL 1979-06-12 fda.gov

Trials 3 · a red edge is where a trial was stopped

1978197919801981198219831984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 21 trial
Phase 2 NCT07263438 Nov 2025 → Mar 2028 expected glioblastoma Centre Hospitalier Universitaire Vaudois Recruiting No outcome recorded
Phase 31 trial
Phase 3 NCT02374567 Jan 2015 → Jun 2017 anxiety disorder, dementia, depressive disorder, schizophrenia +1 Hannover Medical School Terminated No outcome recorded
Phase 41 trial
Phase 4 NCT02237937 Sep 2011 → Dec 2014 major depressive disorder HolsboerMaschmeyer NeuroChemie GmbH Unknown No outcome recorded

Evidence & citations 17 cited values

Every value below carries the sentence it was read from. 4 sources stand behind the page.

FieldValueCited text
Known as Trimipramine ClinicalTrials.gov intervention name — accepted as the source's own label NCT07263438
2

NCT02374567

NCT02237937

Known as 7162 RP ChEMBL registry synonym — accepted as the source's own label CHEMBL644
Known as IL 6001 ChEMBL registry synonym — accepted as the source's own label CHEMBL644
Known as NSC-758386 ChEMBL registry synonym — accepted as the source's own label CHEMBL644
Known as Stangyl ChEMBL registry synonym — accepted as the source's own label CHEMBL644
Known as Surmontil ChEMBL registry synonym — accepted as the source's own label CHEMBL644
Known as Trimeproprimine ChEMBL registry synonym — accepted as the source's own label CHEMBL644
Known as Trimipramina ChEMBL registry synonym — accepted as the source's own label CHEMBL644
Known as TRIMIPRAMINE MALEATE ChEMBL registry synonym — accepted as the source's own label CHEMBL644
Action Inhibit “Serotonin 2c (5-HT2c) receptor antagonist” CHEMBL644
4

“Serotonin 2a (5-HT2a) receptor antagonist” CHEMBL644

“Norepinephrine transporter inhibitor” CHEMBL644

“Histamine H1 receptor antagonist” CHEMBL644

“Dopamine D2 receptor antagonist” CHEMBL644

Modality Small molecule CHEMBL644
Route Oral “daily oral intake” NCT07263438
Target DRD2 “Dopamine D2 receptor antagonist” CHEMBL644
Target HRH1 “Histamine H1 receptor antagonist” CHEMBL644
Target HTR2A “Serotonin 2a (5-HT2a) receptor antagonist” CHEMBL644
Target HTR2C “Serotonin 2c (5-HT2c) receptor antagonist” CHEMBL644
Target SLC6A2 “Norepinephrine transporter inhibitor” CHEMBL644